Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.58 |
| ▸ | GLP1R | P43220 | 15/20 | 0.56 |
| ▸ | SCTR | P47872 | 1/20 | 0.56 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.52 |
| ▸ | GCGR | P47871 | 1/20 | 0.52 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.50 |
| ▸ | NPY1R | P25929 | 1/20 | 0.50 |
| ▸ | NPY2R | P49146 | 1/20 | 0.50 |
| ▸ | NPY4R | P50391 | 1/20 | 0.50 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.50 |
| ▸ | VIPR2 | P41587 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30607419 | 0.91 | GLP1R (0.65) | TFPIGLP1RSCTRGCGRNPY1R | |
| SCHEMBL30512688 | 0.89 | TFPI (0.55) | TFPIGLP1RSCTRC5AR1 | |
| SCHEMBL29594112 | 0.89 | GLP1R (0.58) | TFPIGLP1RSCTRC5AR1GCGR | |
| SCHEMBL30262091 | 0.88 | VIPR2 (0.58) | TFPIGLP1RSCTRGCGRVIPR2 | |
| SCHEMBL30512627 | 0.88 | TFPI (0.64) | TFPIGLP1RSCTRC5AR1GCGR | |
| SCHEMBL30307618 | 0.87 | GLP1R (0.67) | TFPIGLP1RSCTRGCGR | |
| SCHEMBL31419706 | 0.87 | TFPI (0.63) | TFPIGLP1RSCTRGCGRVIPR2 | |
| SCHEMBL5500011 | 0.87 | C5AR1 (0.58) | TFPIGLP1RSCTRC5AR1GCGR | |
| SCHEMBL5500020 | 0.87 | C5AR1 (0.58) | TFPIGLP1RSCTRC5AR1GCGR | |
| SCHEMBL30424730 | 0.87 | C5AR1 (0.53) | TFPIGLP1RSCTRC5AR1GCGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11634455-B2 | Amino diacids containing peptide modifiers | CHEMICAL & BIOPHARMACEUTICAL LABORATORIES OF PATRAS S.A. (GR) | 2023-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11634455-B2 | Amino diacids containing peptide modifiers | PTMS, PEPD, VIP | TFPI 3422/4885GLP1R 21/4885SCTR 57/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.